Systemic and central immunity in Alzheimer's disease: therapeutic implications.
about
APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectivePerispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidencePotential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsAlzheimer's disease and disseminated mycoses.Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes.Molecular biomarkers of lung carcinoma.Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic miceImmunotherapies in Alzheimer's disease: Too much, too little, too late or off-target?Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.Impaired Resolution of Inflammation in Alzheimer's Disease: A Review.Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.Metabolomic research on the role of interleukin-4 in Alzheimer’s disease
P2860
Q28085213-92A5C188-A72D-4F45-917E-C351C3228AA2Q33947639-01ECEF7D-1BCB-4285-AF0F-676C85648D8CQ34014237-4A5FC0EF-F910-4FC9-B87B-06990B697A5DQ34039644-613EB19D-CDAA-4151-BCB7-2A65B10F6AA5Q36958266-54307CE9-10C2-42E8-A77B-26084F10CDD6Q37971659-E857DF10-5597-457C-B83C-78732ADCC2B1Q38280315-849C4E20-1844-4E38-8050-177BBDE30F8AQ38675216-52589858-FDDA-4D16-87DC-F130CCA9694AQ39054244-420EC94E-333F-438D-893E-7C1312E31666Q41346723-C2BBB09E-4DDB-4916-8420-A55B701062A8Q42674268-0EA4855C-C348-47F6-A4E3-62C68C12D498Q47133736-9EF760E1-5F7D-40E5-8DC7-AF2879ACBEC4Q51764702-823643AA-6497-4854-A61A-B4F3BD129066Q59275594-E8D2DE37-0744-4DEB-9F8B-EA5A0251F2C4
P2860
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@en
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@nl
type
label
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@en
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@nl
prefLabel
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@en
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@nl
P2860
P1476
Systemic and central immunity in Alzheimer's disease: therapeutic implications.
@en
P2093
Clive Holmes
Joseph Butchart
P2860
P356
10.1111/J.1755-5949.2011.00245.X
P577
2011-03-21T00:00:00Z